v3.25.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Total revenues $ 10,072,214 $ 7,691,016 $ 6,637,456
Cost of goods 8,008,501 5,840,716 4,635,404
Cost of services 797,286 711,304 917,140
Gross profit 1,266,427 1,138,996 1,084,912
Selling, general, and administrative expenses 1,158,473 1,080,871 925,194
Goodwill impairment loss 0 0 40,856
Operating income 107,954 58,125 118,862
Loss on extinguishment of debt 12,726    
Interest expense, net 190,546 271,899 199,813
Loss from continuing operations before income taxes (95,318) (213,774) (80,951)
Income tax benefit (26,387) (31,508) (390)
Loss from continuing operations, net of income taxes (68,931) (182,266) (80,561)
Income from discontinued operations, net of income taxes 48,410 25,431 26,342
Net loss (20,521) (156,835) (54,219)
Net loss attributable to noncontrolling interests included in continuing operations (2,459) (2,232) (312)
Net loss attributable to BrightSpring Health Services, Inc. and subsidiaries $ (18,062) $ (154,603) $ (53,907)
Basic (loss) income per share attributable to common shareholders:      
Continuing operations $ (0.34) $ (1.53) $ (0.68)
Discontinued operations 0.25 0.22 0.22
Net loss (0.09) (1.31) (0.46)
Diluted (loss) income per share attributable to common shareholders:      
Continuing operations (0.34) (1.53) (0.68)
Discontinued operations 0.25 0.22 0.22
Net loss $ (0.09) $ (1.31) $ (0.46)
Weighted average shares outstanding:      
Basic 192,997 117,868 117,840
Diluted 192,997 117,868 117,840
Products      
Total revenues $ 8,754,282 $ 6,522,450 $ 5,264,423
Services      
Total revenues $ 1,317,932 $ 1,168,566 $ 1,373,033